When It Comes to an End: Oxidative Stress Crosstalk with Protein Aggregation and Neuroinflammation Induce Neurodegeneration

被引:70
作者
Michalska, Patrycja [1 ,2 ,3 ]
Leon, Rafael [1 ,2 ,3 ,4 ]
机构
[1] Univ Autonoma Madrid, Fac Med, Inst Teofilo Hernando, Madrid 28029, Spain
[2] Univ Autonoma Madrid, Fac Med, Dept Farmacol & Terapeut, Madrid 28029, Spain
[3] Hosp Univ Princesa, Inst Invest Sanitaria, Serv Farmacol Clin, Madrid 28006, Spain
[4] Consejo Super Invest Cient IQM CSIC, Inst Quim Med, Madrid 28006, Spain
关键词
neurodegenerative diseases; oxidative stress; protein aggregates; neuroinflammation; Nrf2-ARE pathway; reactive species; redox signaling; AMYOTROPHIC-LATERAL-SCLEROSIS; CHAPERONE-MEDIATED AUTOPHAGY; TRANSCRIPTION FACTOR NRF2; ALZHEIMERS-DISEASE BRAIN; FRONTOTEMPORAL LOBAR DEGENERATION; ENDOPLASMIC-RETICULUM STRESS; UBIQUITIN-PROTEASOME SYSTEM; AMYLOID PRECURSOR PROTEIN; REACTIVE OXYGEN; PARKINSONS-DISEASE;
D O I
10.3390/antiox9080740
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Neurodegenerative diseases are characterized by a progressive loss of neurons in the brain or spinal cord that leads to a loss of function of the affected areas. The lack of effective treatments and the ever-increasing life expectancy is raising the number of individuals affected, having a tremendous social and economic impact. The brain is particularly vulnerable to oxidative damage given the high energy demand, low levels of antioxidant defenses, and high levels of metal ions. Driven by age-related changes, neurodegeneration is characterized by increased oxidative stress leading to irreversible neuronal damage, followed by cell death. Nevertheless, neurodegenerative diseases are known as complex pathologies where several mechanisms drive neuronal death. Herein we discuss the interplay among oxidative stress, proteinopathy, and neuroinflammation at the early stages of neurodegenerative diseases. Finally, we discuss the use of the Nrf2-ARE pathway as a potential therapeutic strategy based on these molecular mechanisms to develop transformative medicines.
引用
收藏
页码:1 / 34
页数:34
相关论文
共 313 条
[1]  
Abe K, 1997, NEUROL RES, V19, P124
[2]   β-amyloid stimulation of inducible nitric-oxide synthase in astrocytes is interleukin-1β- and tumor necrosis factor-α (TNFα)-dependent, and involves a TNFα receptor-associated factor- and NFκB-inducing kinase-dependent signaling mechanism [J].
Akama, KT ;
Van Eldik, LJ .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (11) :7918-7924
[3]   Chaperone-Mediated Autophagy Markers in Parkinson Disease Brains [J].
Alvarez-Erviti, Lydia ;
Rodriguez-Oroz, Maria C. ;
Cooper, J. Mark ;
Caballero, Cristina ;
Ferrer, Isidro ;
Obeso, Jose A. ;
Schapira, Anthony H. V. .
ARCHIVES OF NEUROLOGY, 2010, 67 (12) :1464-1472
[4]   TDP-43 is a component of ubiquitin-positive tau-negative inclusions in frontotemporal lobar degeneration and amyotrophic lateral sclerosis [J].
Arai, Tetsuaki ;
Hasegawa, Masato ;
Akiyama, Haruhiko ;
Ikeda, Kenji ;
Nonaka, Takashi ;
Mori, Hiroshi ;
Mann, David ;
Tsuchiya, Kuniaki ;
Yoshida, Marl ;
Hashizume, Yoshio ;
Oda, Tatsuro .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2006, 351 (03) :602-611
[5]   BIOLOGICAL DEFENSE MECHANISMS - PRODUCTION BY LEUKOCYTES OF SUPEROXIDE A POTENTIAL BACTERICIDAL AGENT [J].
BABIOR, BM ;
KIPNES, RS ;
CURNUTTE, JT .
JOURNAL OF CLINICAL INVESTIGATION, 1973, 52 (03) :741-744
[6]   Cytoplasmic Mislocalization of TDP-43 Is Toxic to Neurons and Enhanced by a Mutation Associated with Familial Amyotrophic Lateral Sclerosis [J].
Barmada, Sami J. ;
Skibinski, Gaia ;
Korb, Erica ;
Rao, Elizabeth J. ;
Wu, Jane Y. ;
Finkbeiner, Steven .
JOURNAL OF NEUROSCIENCE, 2010, 30 (02) :639-649
[7]   Fundamentals on the biochemistry of peroxynitrite and protein tyrosine nitration [J].
Bartesaghi, Silvina ;
Radi, Rafael .
REDOX BIOLOGY, 2018, 14 :618-625
[8]   Ten misconceptions about antioxidants [J].
Bast, Aalt ;
Haenen, Guido R. M. M. .
TRENDS IN PHARMACOLOGICAL SCIENCES, 2013, 34 (08) :430-436
[9]   Increased 3-nitrotyrosine in both sporadic and familial amyotrophic lateral sclerosis [J].
Beal, MF ;
Ferrante, RJ ;
Browne, SE ;
Matthews, RT ;
Kowall, NW ;
Brown, RH .
ANNALS OF NEUROLOGY, 1997, 42 (04) :644-654
[10]  
Beckman JS, 1996, AM J PHYSIOL-CELL PH, V271, pC1424